Literature DB >> 15986432

Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression.

Xiu-Mei Cai1, Bei-Bei Tao, Li-Ying Wang, Yu-Long Liang, Jia-Wei Jin, Yong Yang, Ya-Li Hu, Xi-Liang Zha.   

Abstract

PTEN is a major tumor suppressor gene that has been shown to inhibit cell invasion. Its mutation has been found in 20-40% of malignant gliomas. Meanwhile, the type III EGFR mutation (EGFRvIII), which was frequently found in gliomas, promoted cell invasion. In the present study, the effects of PTEN on cell invasion were investigated in U87DeltaEGFR glioblastoma cells with EGFRvIII expression but missing PTEN. The cell invasion was downregulated by transfection of phosphatase-active forms of PTEN (wild-type and G129E) but not by PTEN (C124A) with an inactive phosphatase domain; the effects were correlated with decreased tyrosine phosphatase levels of FAK at Tyr397, which was increased by EGFRvIII. Overexpression of FAK mutant (Y397F) could partially mimic the effect of PTEN on cell invasion. Although EGFRvIII increased the levels of P-Akt and PTEN eliminated it, PI-3K inhibitors, wortmannin or Ly294002, could not decrease the cell invasion. In conclusion, PTEN could inhibit cell invasion even in the presence of the constitutively active EGFR; this inhibition depended on its protein phosphatase activity, partially by dephosphorylating FAK, but not depended on its lipid phosphatase activity. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986432     DOI: 10.1002/ijc.21251

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Authors:  Massod Rahimi; Kai-Ling Huang; Careen K Tang
Journal:  Cancer Lett       Date:  2010-03-17       Impact factor: 8.679

2.  PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation.

Authors:  J-J Lee; B C Kim; M-J Park; Y-S Lee; Y-N Kim; B L Lee; J-S Lee
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

3.  PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts.

Authors:  Hongbo Chen; Lin Mei; Lanzhen Zhou; Xiaomeng Shen; Caiping Guo; Yi Zheng; Huijun Zhu; Yongqiang Zhu; Laiqiang Huang
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

4.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

5.  DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.

Authors:  Yan Tan; Yu-sheng Shi; Xi-dong Wu; Hui-yu Liang; Yu-bo Gao; Shu-ji Li; Xing-mei Zhang; Fang Wang; Tian-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2013-12       Impact factor: 6.150

6.  PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.

Authors:  Stacey L Thomas; Ridwan Alam; Nancy Lemke; Lonni R Schultz; Jorge A Gutiérrez; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

7.  JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.

Authors:  Qifan Zheng; Lei Han; Yucui Dong; Jing Tian; Wei Huang; Zhaoyu Liu; Xiuzhi Jia; Tao Jiang; Jianning Zhang; Xia Li; Chunsheng Kang; Huan Ren
Journal:  Neuro Oncol       Date:  2014-05-25       Impact factor: 12.300

Review 8.  Neomorphic mutations create therapeutic challenges in cancer.

Authors:  V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

9.  Predicting which children are at risk for ependymoma relapse.

Authors:  Kristina Sowar; Jennifer Straessle; Andrew M Donson; Michael Handler; Nicholas K Foreman
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

10.  Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Authors:  S E Wheeler; S Suzuki; S M Thomas; M Sen; R J Leeman-Neill; S I Chiosea; C-T Kuan; D D Bigner; W E Gooding; S Y Lai; J R Grandis
Journal:  Oncogene       Date:  2010-07-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.